Jacoby J H, Bryce G F
Horm Metab Res. 1979 Feb;11(2):90-4. doi: 10.1055/s-0028-1092686.
5-hydroxytryptophan (5HTP), the immediate precursor of serotonin, induces a release of insulin and glucagon in the intact rat. These effects of 5HTP, which have previously been shown to be blocked by L-aromatic amino acid decarboxylase inhibition, were also prevented by methysergide (a serotonin receptor antagonist). Quipazine (a serotonin receptor agonist) did not alter pancreatic hormone release. Fluoxetine, a serotonin neuronal reuptake blocker did not effect insulin secretion and had a slight glucagon stimulatory effect, however the effects of 5HTP on insulin and glucagon release were not potentiated by fluoxetine pretreatment. Alpha and beta-adrenergic receptor blockade did not alter the pancreatic effects of 5HTP.
5-羟色氨酸(5HTP)是血清素的直接前体,可在完整大鼠体内诱导胰岛素和胰高血糖素的释放。5HTP的这些作用先前已被证明可被L-芳香族氨基酸脱羧酶抑制所阻断,麦角新碱(一种血清素受体拮抗剂)也可阻止这些作用。喹哌嗪(一种血清素受体激动剂)不会改变胰腺激素的释放。氟西汀是一种血清素神经元再摄取阻滞剂,对胰岛素分泌没有影响,对胰高血糖素略有刺激作用,然而,氟西汀预处理并未增强5HTP对胰岛素和胰高血糖素释放的作用。α和β肾上腺素能受体阻断不会改变5HTP对胰腺的作用。